Trial	Phase	Sponsor	Dist.
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501	Phase 3	Neumora Therapeutics, Inc.	<1 mi
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder	Phase 3	Neumora Therapeutics, Inc.	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)	Phase 2	Alto Neuroscience	<1 mi
Assessing Improvements in Mood and Sleep Trial	N/A	University of Pittsburgh	<1 mi
Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements	—	Kernel	<1 mi
Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression	—	University of California, Los Angeles	<1 mi
Pain and Major Depressive Disorder	N/A	University of California, Los Angeles	<1 mi
In-patient SCC TMS	N/A	University of California, Los Angeles	<1 mi
Improving Behavioral Health for Caregivers and Children After Pediatric Injury	N/A	Medical University of South Carolina	<1 mi
RCT of Psilocybin-assisted CBT for Depression	Phase 1/2	University of California, Los Angeles	<1 mi
Regulation of Affect and Physiology in Depression	Phase 2	University of Southern California	<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	<1 mi
Model-based Electrical Brain Stimulation	N/A	University of Southern California	<1 mi
Evaluating tDCS Brain-stimulation in Depression Using MRI	N/A	University of California, Los Angeles	<1 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Training Reward Responsiveness Through Virtual Reality	Phase 2	University of California, Los Angeles	<1 mi
Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy	N/A	University of California, Los Angeles	<1 mi
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis	N/A	Children's Hospital Medical Center, Cincinnati	<1 mi
RCT for Latina Mental Health Using Web-Based Apps	N/A	University of California, Los Angeles	<1 mi
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women	Phase 2/3	Cedars-Sinai Medical Center	<1 mi
S.T.A.N.D. Alacrity Center Signature Project	N/A	University of California, Los Angeles	<1 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia	Phase 2	Syndeio Biosciences, Inc	<1 mi
Personalized Accelerated TMS for High-Risk Adolescent Depression	N/A	University of California, Davis	<1 mi
A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations	N/A	Stanford University	<1 mi
Biomarkers of Depression and Treatment Response	N/A	University of California, San Francisco	<1 mi
Using Electrophysiology to Index Non-invasive Brain Stimulation Effects on Reward System Functioning in Depression	N/A	San Francisco Veterans Affairs Medical Center	<1 mi
Reward Processing and Depressive Subtypes: Identifying Neural Biotypes	—	San Francisco Veterans Affairs Medical Center	<1 mi
Better Sleep Study	N/A	University of California, San Francisco	<1 mi
Building Resilience for Surgical Recovery	N/A	The University of Texas Health Science Center, Houston	<1 mi
Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression	N/A	Andrew Krystal	<1 mi
Probiotic Administration for Adolescent Depression	Early 1	University of California, San Francisco	<1 mi
Treating Major Depression With Yoga Mono-therapy	N/A	University of California, San Francisco	<1 mi
Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2	N/A	University of California, San Francisco	<1 mi
Near Infrared Spectroscopy (NIRS) for Assessment of Depression	N/A	University of California, San Francisco	<1 mi
Closed-Loop Deep Brain Stimulation for Major Depression	N/A	Andrew Krystal	<1 mi
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)	Phase 3	Cybin IRL Limited	<1 mi
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project	—	University of Southern California	<1 mi
SUpport From PEeRs to Expand Access Study - Community	N/A	University of California, Berkeley	<1 mi
Ketamine for Veterans With Parkinson's Disease	Phase 2	VA Office of Research and Development	<1 mi
Psilocybin Therapy for Depression in Parkinson's Disease	Phase 2	Joshua Woolley, MD, PhD	<1 mi
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder	Phase 2	Janssen Research & Development, LLC	<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression	Phase 2	Draig Therapeutics Ltd	<1 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches	N/A	Veterans Medical Research Foundation	<1 mi
Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction	N/A	University of California, San Diego	<1 mi
Feasibility of a Prenatal Yoga Mobile App in African American Pregnant Women	N/A	San Diego State University	<1 mi
Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study	N/A	University of California, San Diego	<1 mi
Maintenance rTMS for Depression (Maitr-De)	N/A	University of California, San Diego	<1 mi
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI	N/A	University of California, San Diego	<1 mi
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)	Phase 2/3	University of California, San Diego	<1 mi
Pramipexole to Enhance Social Connections	Phase 2	University of California, San Diego	<1 mi
Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans	N/A	VA Office of Research and Development	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	<1 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	6 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	6 mi
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	6 mi
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)	—	Janssen Research & Development, LLC	6 mi
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder	Phase 3	Neumora Therapeutics, Inc.	7 mi
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder	Phase 2	Sirtsei Pharmaceuticals, Inc.	8 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	8 mi
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness	Phase 2	Brigham and Women's Hospital	9 mi
Filipino Family Health Initiative 1.0	N/A	Kaiser Permanente	9 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	9 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	10 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder	Phase 3	Intra-Cellular Therapies, Inc.	10 mi
Kintsugi Voice Device Pivotal Study	—	Kintsugi Mindful Wellness, Inc.	10 mi
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms	Phase 2	University of California, Los Angeles	11 mi
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)	Phase 3	Definium Therapeutics US, Inc.	11 mi
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression	N/A	University of California, San Diego	11 mi
Mindfulness Engaged Neurostimulation for Depression	Phase 2	University of California, San Diego	11 mi
Meditative Neurofeedback for Depression	N/A	University of California, San Diego	11 mi
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	Phase 4	Neurocrine Biosciences	14 mi
A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression	Phase 1	Sirtsei Pharmaceuticals, Inc.	15 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	15 mi
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder	N/A	Stanford University	16 mi
Sensory Synchronized Imaging and Neuromodulation	N/A	VA Office of Research and Development	16 mi
rTMS for Military TBI-related Depression	N/A	Henry M. Jackson Foundation for the Advancement of Military Medicine	16 mi
Sleep Mechanisms Of Regulating Emotions	N/A	Stanford University	16 mi
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy	Phase 2	City of Hope Medical Center	16 mi
Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers	N/A	City of Hope Medical Center	16 mi
Optimizing Brain Excitability in Depression	N/A	Stanford University	17 mi
Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans	N/A	Stanford University	17 mi
Behavioral and Neuronal Correlates of Human Mood States	N/A	Stanford University	17 mi
Closed-loop Optimized rTMS for Depression	N/A	Stanford University	17 mi
The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia	N/A	Stanford University	17 mi
fMRI Neurofeedback With Matter Neuroscience App	N/A	Stanford University	17 mi
Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression	N/A	Stanford University	17 mi
Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression	N/A	Stanford University	17 mi
Biomarker-guided rTMS for Treatment Resistant Depression	Phase 3	Weill Medical College of Cornell University	17 mi
The BEAR Program for Women With Trauma Who Have Suicidal Thoughts	N/A	Stanford University	17 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age	—	State University of New York at Buffalo	20 mi
Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults	Phase 2	Autobahn Therapeutics, Inc.	21 mi
Positive Affect Treatment for Adolescents with Early Life Adversity	N/A	University of California, Irvine	22 mi
A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD	Phase 3	Lipocine Inc.	23 mi
Mindful Self-Compassion to Address PTSD and Substance Use in Unhoused Women	N/A	University of California, Los Angeles	28 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Phase 2	ACADIA Pharmaceuticals Inc.	32 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	36 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.